{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:42:33Z","timestamp":1793814153149,"version":"4.6.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institutes on Drug Abuse","doi-asserted-by":"crossref","award":["R01DA040488"],"award-info":[{"award-number":["R01DA040488"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.drugpo.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T01:06:51Z","timestamp":1532999211000},"page":"94-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-979X","authenticated-orcid":false,"given":"Karin","family":"Tobin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catie","family":"Clyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Davey-Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7931-2116","authenticated-orcid":false,"given":"Carl","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.drugpo.2018.07.003_bib0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/M14-0019","article-title":"A cascade of care for diabetes in the United States: Visualizing the gaps","volume":"161","author":"Ali","year":"2014","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0010","series-title":"Baltimore city health commissioner signs new standing order for opioid overdose reversal medication","author":"Baltimore City Health Department","year":"2017"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0015","series-title":"Substance use and misuse","author":"Baltimore City Health Department","year":"2017"},{"issue":"2","key":"10.1016\/j.drugpo.2018.07.003_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2018.07.003_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2458-14-297","article-title":"Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: A retrospective cohort study","volume":"14","author":"Doe-Simkins","year":"2014","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2018.07.003_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13722-016-0068-3","article-title":"Opioid overdose prevention and naloxone rescue kits: What we know and what we don\u2019t know","volume":"12","author":"Kerensky","year":"2017","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsat.2016.07.005","article-title":"Awareness and attitudes toward intranasal naloxone rescue for opioid overdose prevention","volume":"69","author":"Kirane","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.drugpo.2018.07.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097317","article-title":"The hepatitis C cascade of care: Identifying priorities to improve clinical outcomes","volume":"9","author":"Linas","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugpo.2016.11.015","article-title":"Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study","volume":"41","author":"Marshall","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0050","series-title":"Drug- and alcohol-related intoxication deaths in Maryland, 2016","author":"Maryland Department of Health and Mental Hygiene","year":"2017"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0055","series-title":"Naloxone and the statewide standing order: What you need to know","author":"Maryland Department of Health and Mental Hygiene","year":"2017"},{"key":"10.1016\/j.drugpo.2018.07.003_bib0060","series-title":"Pharmacies that stock naloxone","author":"Maryland Department of Health and Mental Hygiene","year":"2017"},{"issue":"2","key":"10.1016\/j.drugpo.2018.07.003_bib0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice","volume":"36","author":"Mueller","year":"2015","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.drugpo.2018.07.003_bib0070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1360-0443.2010.03146.x","article-title":"The STEP into action study: A peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland","volume":"106","author":"Tobin","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2018.07.003_bib0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/2042098614564776","article-title":"Review of naloxone safety for opioid overdose: Practical considerations for new technology and expanded public access","volume":"6","author":"Wermeling","year":"2015","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"6","key":"10.1016\/j.drugpo.2018.07.003_bib0080","first-page":"101","article-title":"Community-based opioid overdose prevention programs providing naloxone \u2013 United States, 2010","volume":"61","author":"Wheeler","year":"2012","journal-title":"MMWR Morbidity and Mortality Weekly Report"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918301919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918301919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T12:58:35Z","timestamp":1538053115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395918301919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":16,"alternative-id":["S0955395918301919"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.07.003","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}